Please assess the completion status of the following clinical trial:

Trial Title: Clinical Pharmacology of FYU-981 (Elder Subjects)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Japanese adult subjects~* 20-35 Years (non-elder groups)~* 65- Years (elder groups)~* Body mass index: \>=18.5 and \<25.0~Exclusion Criteria:~* Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Male elder subjects (Type: EXPERIMENTAL): Male 65- Years
- Male non-elder subjects (Type: EXPERIMENTAL): Male 20-35 Years
- Female elder subjects (Type: EXPERIMENTAL): Female 65- Years
- Female non-elder subjects (Type: EXPERIMENTAL): Female 20-35 Years

Based on this trial design, predict the completion outcome and termination type (if applicable).